NIH | National Cancer Institute | NCI Wiki  

WIKI MAINTENANCE NOTICE

Please be advised that NCI Wiki will be will be undergoing maintenance on Monday, June 24th between 1000 ET and 1100 ET.
Wiki will remain available, but users may experience screen refreshes or HTTP 502 errors during the maintenance period. If you encounter these errors, wait 1-2 minutes, then refresh your page.

If you have any questions or concerns, please contact the CBIIT Atlassian Management Team.

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 8 Next »

Date

Attendees



Goals

Discussion items

ItemWhoNotes
Introduction for Gina KuffelTodd
SC MeetingRalph
ICDC SiteTodd/Gina
  • Data submission
  • Development priorities
  • Site review
  • Next release: Sept 13th
ICDC Next PhaseToby
  • Motivate data submitters
  • Potentially involve other institutes
OtherTodd/Gina
  • Reminder:  No August meeting

Minutes (Not Verbatim)

TP- Next expected release is Sept. 13th. There is a new multi-study participant feature that illustrates canines that were enrolled in multiple studies, this feature is reliant on metadata, such as the biobank_id to discern this designation. Another feature in progress is the extension of the amount of data available for download through the user interface to be inclusive of all metadata that has been loaded into the data commons, at the moment this extended metatdata is only available through the API. Are there other priorities that we should be aware of? ICDC is aiming for quarterly releases.

TH- Do we have any data on the microevironment, anything other than omics type data?

TP- We do link out to TCGA and other imaging repositories.

TH- We need to capture immune modulators and other types of trials, we need a way of adding that type of data such as treating dogs with various agents, canine biopsies, circulating tumor DNA, etc.

CS- Flow data was considered for ICDC. We talked about getting the numbers, but maybe we need to get the raw data. We didn't address if we would bring in raw flow cytometry data.

TP- Nothing prevents us from getting that type of data into our data model.

CS- If we could maybe provide small financial support that may help people get over the hump and encourage data submission.

TP- Let me talk to Ralph to see if we can find a path to use the honorarium to do this.

TH- We are below on spending, we could use that.

TP- It may come with a ceiling that we need to live with, but we can try to get a mechanism in place.

RP- We do have a mechanism in place that involves a Material Transfer Agreement (MTA), no ceiling on that. We can look into this, it comes out of the legal office, maybe we can set up a conference between the 4 of us

TH- Potent





Action items

  • No labels